216 related articles for article (PubMed ID: 10334497)
1. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
Gallate JE; Saharov T; Mallet PE; McGregor IS
Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497
[TBL] [Abstract][Full Text] [Related]
2. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716.
Gallate JE; McGregor IS
Psychopharmacology (Berl); 1999 Mar; 142(3):302-8. PubMed ID: 10208323
[TBL] [Abstract][Full Text] [Related]
3. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
Norwood CS; Cornish JL; Mallet PE; McGregor IS
Eur J Pharmacol; 2003 Mar; 465(1-2):105-14. PubMed ID: 12650839
[TBL] [Abstract][Full Text] [Related]
4. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid modulation of rat pup ultrasonic vocalizations.
McGregor IS; Dastur FN; McLellan RA; Brown RE
Eur J Pharmacol; 1996 Oct; 313(1-2):43-9. PubMed ID: 8905327
[TBL] [Abstract][Full Text] [Related]
6. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.
Gallate JE; Mallet PE; McGregor IS
Psychopharmacology (Berl); 2004 Apr; 173(1-2):210-6. PubMed ID: 14663553
[TBL] [Abstract][Full Text] [Related]
7. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
Braida D; Pozzi M; Cavallini R; Sala M
Neuroscience; 2001; 104(4):923-6. PubMed ID: 11457579
[TBL] [Abstract][Full Text] [Related]
8. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
Cadogan AK; Alexander SP; Boyd EA; Kendall DA
J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
[TBL] [Abstract][Full Text] [Related]
9. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
10. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system.
Braida D; Pozzi M; Parolaro D; Sala M
Eur J Pharmacol; 2001 Feb; 413(2-3):227-34. PubMed ID: 11226397
[TBL] [Abstract][Full Text] [Related]
12. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
14. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
15. Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour.
McGregor IS; Dam KD; Mallet PE; Gallate JE
Alcohol Alcohol; 2005; 40(1):35-45. PubMed ID: 15550450
[TBL] [Abstract][Full Text] [Related]
16. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
Gifford AN; Samiian L; Gatley SJ; Ashby CR
Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770
[TBL] [Abstract][Full Text] [Related]
17. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.
Murphy JW; Kendall DA
Biochem Pharmacol; 2003 May; 65(10):1623-31. PubMed ID: 12754098
[TBL] [Abstract][Full Text] [Related]
18. Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens.
Pertwee RG; Joe-Adigwe G; Hawksworth GM
Eur J Pharmacol; 1996 Jan; 296(2):169-72. PubMed ID: 8838453
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716.
Higgs S; Williams CM; Kirkham TC
Psychopharmacology (Berl); 2003 Feb; 165(4):370-7. PubMed ID: 12447606
[TBL] [Abstract][Full Text] [Related]
20. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
Meschler JP; Kraichely DM; Wilken GH; Howlett AC
Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
